BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 24709063)

  • 21. Chronology of genetic changes in the vpu, env, and Nef genes of chimeric simian-human immunodeficiency virus (strain HXB2) during acquisition of virulence for pig-tailed macaques.
    McCormick-Davis C; Zhao LJ; Mukherjee S; Leung K; Sheffer D; Joag SV; Narayan O; Stephens EB
    Virology; 1998 Sep; 248(2):275-83. PubMed ID: 9721236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The S68G polymorphism is a compensatory mutation associated with the drug resistance mutation K65R in CRF01_AE strains.
    Li S; Ouyang J; Zhao B; An M; Wang L; Ding H; Zhang M; Han X
    BMC Infect Dis; 2020 Feb; 20(1):123. PubMed ID: 32046664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Infection of rhesus macaques with a pool of simian immunodeficiency virus with the envelope genes from acute HIV-1 infections.
    Krebs KC; Tian M; Asmal M; Ling B; Nelson K; Henry K; Gibson R; Li Y; Han W; Shattock RJ; Veazey RS; Letvin N; Arts EJ; Gao Y
    AIDS Res Ther; 2016 Nov; 13(1):41. PubMed ID: 27906032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infectious simian/human immunodeficiency virus with human immunodeficiency virus type 1 subtype C from an African isolate: rhesus macaque model.
    Ndung'u T; Lu Y; Renjifo B; Touzjian N; Kushner N; Pena-Cruz V; Novitsky VA; Lee TH; Essex M
    J Virol; 2001 Dec; 75(23):11417-25. PubMed ID: 11689623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced infectivity of an R5-tropic simian/human immunodeficiency virus carrying human immunodeficiency virus type 1 subtype C envelope after serial passages in pig-tailed macaques (Macaca nemestrina).
    Chen Z; Huang Y; Zhao X; Skulsky E; Lin D; Ip J; Gettie A; Ho DD
    J Virol; 2000 Jul; 74(14):6501-10. PubMed ID: 10864663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sensitivity/resistance profile of a simian immunodeficiency virus containing the reverse transcriptase gene of human immunodeficiency virus type 1 (HIV-1) toward the HIV-1-specific non-nucleoside reverse transcriptase inhibitors.
    Balzarini J; Weeger M; Camarasa MJ; De Clercq E; Uberla K
    Biochem Biophys Res Commun; 1995 Jun; 211(3):850-6. PubMed ID: 7541200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular cloning and in vitro evaluation of an infectious simian-human immunodeficiency virus containing env of a primary Chinese HIV-1 subtype C isolate.
    Wu Y; Hong K; Chenine AL; Whitney JB; Xu W; Chen Q; Geng Y; Ruprecht RM; Shao Y
    J Med Primatol; 2005 Apr; 34(2):101-7. PubMed ID: 15860117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Construction and infection of a new simian/human immunodeficiency chimeric virus (SHIV) containing the integrase gene of the human immunodeficiency virus type 1 genome and analysis of its adaptation to monkey cells.
    Akiyama H; Ishimatsu M; Miura T; Hayami M; Ido E
    Microbes Infect; 2008 Apr; 10(5):531-9. PubMed ID: 18403228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel Transmitted/Founder Simian-Human Immunodeficiency Viruses for Human Immunodeficiency Virus Latency and Cure Research.
    Bauer AM; Ziani W; Lindemuth E; Kuri-Cervantes L; Li H; Lee FH; Watkins M; Ding W; Xu H; Veazey R; Bar KJ
    J Virol; 2020 Mar; 94(8):. PubMed ID: 31969435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of viremia and evolution of human immunodeficiency virus type 1 drug resistance in a macaque model for antiretroviral therapy.
    Ambrose Z; Palmer S; Boltz VF; Kearney M; Larsen K; Polacino P; Flanary L; Oswald K; Piatak M; Smedley J; Shao W; Bischofberger N; Maldarelli F; Kimata JT; Mellors JW; Hu SL; Coffin JM; Lifson JD; KewalRamani VN
    J Virol; 2007 Nov; 81(22):12145-55. PubMed ID: 17855539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Augmentation of human immunodeficiency virus type 1 subtype E (CRF01_AE) multiple-drug resistance by insertion of a foreign 11-amino-acid fragment into the reverse transcriptase.
    Sato H; Tomita Y; Ebisawa K; Hachiya A; Shibamura K; Shiino T; Yang R; Tatsumi M; Gushi K; Umeyama H; Oka S; Takebe Y; Nagai Y
    J Virol; 2001 Jun; 75(12):5604-13. PubMed ID: 11356968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Species tropism of chimeric SHIV clones containing HIV-1 subtype-A and subtype-E envelope genes.
    Himathongkham S; Douglas GC; Fang A; Yu E; Barnett SW; Luciw PA
    Virology; 2002 Jul; 298(2):189-99. PubMed ID: 12127782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Susceptibility of HIV-2, SIV and SHIV to various anti-HIV-1 compounds: implications for treatment and postexposure prophylaxis.
    Witvrouw M; Pannecouque C; Switzer WM; Folks TM; De Clercq E; Heneine W
    Antivir Ther; 2004 Feb; 9(1):57-65. PubMed ID: 15040537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Innate differences between simian-human immunodeficiency virus (SHIV)(KU-2)-infected rhesus and pig-tailed macaques in development of neurological disease.
    Buch SJ; Villinger F; Pinson D; Hou Y; Adany I; Li Z; Dalal R; Raghavan R; Kumar A; Narayan O
    Virology; 2002 Mar; 295(1):54-62. PubMed ID: 12033765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Construction of human immunodeficiency virus 1/simian immunodeficiency virus strain mac chimeric viruses having vpr and/or nef of different parental origins and their in vitro and in vivo replication.
    Kuwata T; Igarashi T; Ido E; Jin M; Mizuno A; Chen J; Hayami M
    J Gen Virol; 1995 Sep; 76 ( Pt 9)():2181-91. PubMed ID: 7561755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increase of RT-related transmitted drug resistance in non-CRF01_AE among HIV type 1-infected men who have sex with men in the 7 cities of China.
    Zhao B; Han X; Xu J; Hu Q; Chu Z; Zhang J; Lu L; Wang Z; Fu J; Chen X; Yan H; Zhuang M; Wang L; Sun A; Zhang CM; Shang H
    J Acquir Immune Defic Syndr; 2015 Mar; 68(3):250-5. PubMed ID: 25469530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppression of acute viremia by short-term postexposure prophylaxis of simian/human immunodeficiency virus SHIV-RT-infected monkeys with a novel reverse transcriptase inhibitor (GW420867) allows for development of potent antiviral immune responses resulting in efficient containment of infection.
    Mori K; Yasutomi Y; Sawada S; Villinger F; Sugama K; Rosenwith B; Heeney JL; Uberla K; Yamazaki S; Ansari AA; Rübsamen-Waigmann H
    J Virol; 2000 Jul; 74(13):5747-53. PubMed ID: 10846052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A nucleotide substitution in the tRNA(Lys) primer binding site dramatically increases replication of recombinant simian immunodeficiency virus containing a human immunodeficiency virus type 1 reverse transcriptase.
    Soderberg K; Denekamp L; Nikiforow S; Sautter K; Desrosiers RC; Alexander L
    J Virol; 2002 Jun; 76(11):5803-6. PubMed ID: 11992009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low Frequency of Drug-Resistant Variants Selected by Long-Acting Rilpivirine in Macaques Infected with Simian Immunodeficiency Virus Containing HIV-1 Reverse Transcriptase.
    Melody K; McBeth S; Kline C; Kashuba AD; Mellors JW; Ambrose Z
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7762-70. PubMed ID: 26438501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Infection of a chimeric simian and human immunodeficiency virus with CCR5-specific HIV-1 envelope to Rhesus macaques.
    Enose Y; Miyake A; Ido E; Hayami M
    J Vet Med Sci; 2003 Feb; 65(2):283-6. PubMed ID: 12655130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.